Skip to content

To evaluate the safety and efficacy of Ahmadi anti-aging cream in skin rejuvenation

Evaluation of safety and efficacy of Ahmadi anti-aging cream in skin rejuvenation and improving skin wrinkle

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190210042676N6
Enrollment
20
Registered
2020-05-14
Start date
2019-12-22
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin aging.

Interventions

Intervention group: Topical use of Ahmadi rejuvenating cream manufactured by Ahmadi Company for 8 weeks..

Sponsors

Javansaz Ahmadi Company
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: In terms of wrinkles, the skin should be grade 2 or 3 according to the Glogau scale. Signing the consent form for participation in the study

Exclusion criteria

Exclusion criteria: Volunteers should not use any cream other than sunscreen and moisturizer,during the study. History of any type of cosmetic surgery over the past 3 years at the treatment site History of using RF within the past year History of botulinum toxin injection, laser or intense pulsed light within the past 6 months Any immunodeficiency or use of immunosuppressive drugs (cancer, chronic liver and kidney disease, etc.) Pregnancy or lactating Active smoker in last 2 years

Design outcomes

Primary

MeasureTime frame
Changing in facial skin wrinkle using global aesthetic improvement scale. Timepoint: before intervention , 4 and 8 weeks later. Method of measurement: One independent dermatologist will perform clinical assessments in a blinded fashion by scoring every photograph according to the global aesthetic improvement scale .

Secondary

MeasureTime frame
Skin elasticity. Timepoint: before intervention and 4 and 8 weeks later. Method of measurement: Cutometery.;Area and volume of nasolabial fold. Timepoint: before intervention and 4 and 8 weeks later. Method of measurement: VisioFace.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAniseh Samadi

Tehran University of Medical Sciences

aniseh_samadi@yahoo.com+98 21 8896 0880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026